Irinotecan/capecitabine versus cisplatin/capecitabine in advanced adenocarcinoma of the stomach or gastroesophageal junction: Interimsanalysis of a german AIO phase II study

被引：0
|
作者：
Moehler, M.
Kanzler, S.
Geissler, M.
Raedle, J.
Ebert, M.
Scherubl, H.
Flieger, D.
Seufferlein, T.
Galle, P. R.
Hoehler, T.
机构：
[1] Univ Mainz, Dept Med 1, D-6500 Mainz, Germany
[2] Univ Freiburg, Dept Med, D-7800 Freiburg, Germany
[3] Univ Homburg, Dept Med, D-6650 Homburg, Germany
[4] Univ Magdeburg, Dept Med, D-39106 Magdeburg, Germany
[5] Dept Med, Berlin, Germany
[6] Klinikum Aschaffenburg, Dept Med, Aschaffenburg, Germany
[7] Univ Ulm, Dept Med, D-89069 Ulm, Germany
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：313 / 313
页数：1
相关论文
共 50 条
  • [41] DOCETAXEL, CISPLATIN AND CAPECITABINE (DCX) AS PERIOPERATIVE CHEMOTHERAPY IN GASTRO-ESOPHAGEAL ADENOCARCINOMA. (A PHASE II STUDY OF THE ARBEITSGEMEINSCHAFT INTERNISTISCHE ONKOLOGIE AIO)
    Bichev, D.
    Hofheinz, R.
    Arnold, D.
    Florschuetz, A.
    Daum, S.
    Kretzschmar, A.
    Mantovani-Loeffler, L.
    Schumacher, G.
    Thuss-Patience, P. C.
    Kneba, M.
    ANNALS OF ONCOLOGY, 2010, 21 : 252 - 252
  • [42] Docetaxel, cisplatin and capecitabine (DCX) as perioperative chemotherapy in gastro-esophageal adenocarcinoma. (A phase II study of the Arbeitsgemeinschaft Internistische Onkologie AIO)
    Gahn, B.
    Bichev, D.
    Hofheinz, R.
    Arnold, D.
    Florschuetz, A.
    Daum, S.
    Kretzschmar, A.
    Mantovani-Loeffler, L.
    Kneba, M.
    Reichardt, P.
    Schumacher, G.
    Thuss-Patience, P. C.
    ONKOLOGIE, 2010, 33 : 267 - 268
  • [43] Phase II study of capecitabine and cisplatin in previously untreated advanced biliary tract cancer
    Hong, Yong Sang
    Lee, Jeeyun
    Lee, Sang Cheol
    Hwang, In Gyu
    Choi, Seong-Ho
    Heo, Jin-Seok
    Park, Joon Oh
    Park, Young Suk
    Lim, Ho Yeong
    Kang, Won Ki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (03) : 321 - 328
  • [44] Phase II study of gemcitabine, capecitabine and cisplatin in patients with advanced pancreatic cancer.
    Chang, HM
    Kim, TW
    Ahn, JH
    Ryu, MH
    Lee, JS
    Kim, WK
    Kang, YK
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 368S - 368S
  • [45] Phase II study of capecitabine and cisplatin in previously untreated advanced biliary tract cancer
    Yong Sang Hong
    Jeeyun Lee
    Sang Cheol Lee
    In Gyu Hwang
    Seong-Ho Choi
    Jin-Seok Heo
    Joon Oh Park
    Young Suk Park
    Ho Yeong Lim
    Won Ki Kang
    Cancer Chemotherapy and Pharmacology, 2007, 60 : 321 - 328
  • [46] CISPLATIN AND CAPECITABINE IN HEAVILY PRETREATED ADVANCED BREAST CANCER DISEASE: A PHASE II STUDY
    Donadio, Michela
    Beano, Alessandra
    Ardine, Mara
    Mistrangelo, Marinella
    Bonardi, Simone
    Castiglione, Federico
    Polimeni, Maria Antonia
    Forti, Laura
    Bottini, Alberto
    Bertetto, Oscar
    ANNALS OF ONCOLOGY, 2004, 15 : 18 - 18
  • [47] A multicentre, open-label phase II study of irinotecan, capecitabine, and oxaliplatin (IXO) as first-line treatment in patients with metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma
    Lui, Arthur Gregory Ang
    Mulder, Karen E.
    Brezden-Masley, Christine
    Vickers, Michael M.
    Monzon, Jose Gerard
    Kennecke, Hagen F.
    Goel, Rakesh
    Ghosh, Sunita
    Marginean, Horia
    Vos, Larissa Joy
    Raynard, SeeSee Juliana
    Young, Kristine Lee
    Fields, Anthony L. A.
    Maroun, Jean Alfred
    Spratlin, Jennifer L.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [48] Phase II trial of irinotecan and capecitabine in patients with advanced colorectal cancer (ACRC)
    Ahn, JB
    Jung, KH
    Park, YS
    Kim, YH
    Chang, HJ
    Sohn, DK
    Lim, SB
    Choi, HS
    Jeong, SY
    Park, JG
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 299S - 299S
  • [49] A Randomized Phase II Study of FOLFOX With or Without the MET Inhibitor Onartuzumab in Advanced Adenocarcinoma of the Stomach and Gastroesophageal Junction
    Shah, Manish A.
    Cho, Jae-Yong
    Tan, Iain B.
    Tebbutt, Niall C.
    Yen, Chia-Jui
    Kang, Alice
    Shames, David S.
    Bu, Lilian
    Kang, Yoon-Koo
    ONCOLOGIST, 2016, 21 (09): : 1085 - 1090
  • [50] A randomized phase II study of irinotecan plus cisplatin versus irinotecan plus capecitabine with or without isosorbide-5-mononitrate in advanced non-small-cell lung cancer
    Han, J. Y.
    Nam, B. H.
    Kim, H. Y.
    Yoon, S. J.
    Kim, H. T.
    Lee, J. S.
    ANNALS OF ONCOLOGY, 2012, 23 (11) : 2925 - 2930
12345